Aurora Biotechnologies Inc., to exhibit line of high precision microplates for high thoughput screening and high content cell image analysis at Association for Laboratory Automation, Palm Springs California.
Pioneer in miniaturization to expand into cell imaging analysis
San Diego, Calif., Jan. 27 /PRNewswire-FirstCall/ -- Aurora Biotechnologies Inc., a privately held company, today announced that it will participate in the Association for Laboratory Automation, January 27 to January 31 in Palm Springs, California. The company will use this event to present its new product and application program after it divested its instrumentation business to Beckman Coulter in Septenber, 2006. “We are delighted to be here and demonstrate to our customers and partners that we have established ourselves as the premier microplate platform provider for High Throughput Screening, High Content analysis, Cell Image analysis and Compound Storage. Our unique Cyclo Olefin Polymer based microplates offer significant benefits for these applications”, commented Peter Coassin, co-founder and Chief Technology. Mr. Coassin continued:”Our current program is the start of a series of new products we plan to add throughout 2007 to maintain our world leadership in high precision and performance microplates”.

About Aurora Biotechnologies
Aurora Biotechnology’s is dedicated to improve high throughput and high content assay performance by applying its proprietary and unique assay platform technology and know how. Aurora Biotechnologies™ microplate products are constructed of cyclo-olefin polymer (COP) which has distinctive physical and chemical properties that are superior to polystyrene and polypropylene. Unlike conventional microplates, COP creates a superior combination of optimal clarity, thermal stability, biocompatibility, low auto-fluorescence, flatness and chemical resistance. Based in San Diego, California, more information about Aurora Biotechnologies can be found on the web at http://www.aurorabiotechnologies.com.